The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.
MIT-PB
1 other identifier
interventional
36
1 country
3
Brief Summary
This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2022
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
April 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
ExpectedDecember 10, 2024
December 1, 2024
4 years
March 31, 2022
December 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The quality of General Movement by General Movements Optimality Score (GMOS-R) and Motor Optimality Score (MOS).
We will videotape General Movements at 34, 38-40, 44 and 54 weeks PMA. The baseline measure( 34w) will be performed by the main researcher and an independent and experienced certified rater. This rater will be blind regarding infant group. The assessments at 38-40, 44 and 54 weeks will be performed by the independent, blind and certified rater in order to guarantee the study validity. The GMOS-R global assessment can be Normal (N), Poor Repertoire (PR), Cramped Syncronized (CS) or Chaotic (CH). On the detailed score ,the maximum value is 38. The MOS global assessment can be classified as Fidgety (F), Abnormal Fidgety (AF) or Absent Fidgety (F-). On the detailed score the maximum value is 28. Higher scores in both scales are correlated with better global outcome.
Each participant will be assessed from birth to the 54 weeks PMA.
Secondary Outcomes (2)
Motor development by Hammersmith Infant Neurological Scale (HINE).
6 months CA
Global development by Bayley III
12 months CA
Other Outcomes (2)
Describe families experiences with the MIT-PB
6 months CA
Study family's participation and treatment adherence
6 months CA
Study Arms (2)
Intervention group
EXPERIMENTALThe group intervention will receive MIT-PB.
control group
NO INTERVENTIONThe control group will receive standard care
Interventions
The instant an infant showed CS or PR movements, the therapists (or a therapist and a parent) intervened by gently guiding the infants' limbs so as to maneuver and smoothen their movements, thereby imitating normal GM sequences as closely as possible, adding variability to the movement
Eligibility Criteria
You may qualify if:
- Preterm infants born before 32w GA and less than 1500g weight.
- Infants who show Abnormal General Movements (CS-PR pattern) at 34-36w postmenstrual age (PMA).
- Families able to understand/speak Catalan, Spanish or English.
- Families willing to participate who have the informed consent
You may not qualify if:
- Infants with congenital abnormalities and/or genetic disorders
- Infants with invasive ventilation or Continuous Positive Airway Pressure (CPAP) at 36 weeks PMA.
- Infants with Normal General Movements at 34-36 w PMA.
- Families not willing to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital Sant Joan de Déu
Barcelona, Barcelona, 08950, Spain
Hospital Parc Taulí de Sabadell
Sabadell, BARCELONA, 08208, Spain
Hospital Universitari Josep Trueta de Girona
Girona, Girona, 17007, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana Trallero, MsC
International University of Catalonia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The assessments for the main outcome will be performed by a blinded expert.
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD candidate, MsC, Physiotherapist Susana Trallero Rodríguez
Study Record Dates
First Submitted
March 31, 2022
First Posted
April 8, 2022
Study Start
April 4, 2022
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share